veratrine and Hypertension

veratrine has been researched along with Hypertension* in 9 studies

Other Studies

9 other study(ies) available for veratrine and Hypertension

ArticleYear
Temporal changes in left ventricular function after massive sympathetic nervous system activation.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:6

    Intense activation of the sympathetic nervous system (SNS) decreases the contractile state of the rabbit left ventricle (LV). In this study, we determined the time course of LV dysfunction after massive central activation of the SNS in dogs. Veratrine (40-80 micrograms/kg) was injected intracisternally to activate the SNS in six chloralose-anesthetized dogs, and LV end-diastolic pressure (LVEDP), cardiac output, heart rate, and aortic pressure (Pa) were measured at 30-min intervals for 3 h. Pa increased from 147 +/- 8 (SE) to 272 +/- 7 mmHg (1 mmHg = 133.3 Pa) within 15 min, then declined to 148 +/- 16 mmHg by 1 h LV function curves (stroke work versus LVEDP or stroke work verus LV transmural pressure) showed a marked decrease in slope and a shift to the right within minutes after activating the SNS, which persisted for the duration of the experiment. These data indicate that LV contractility was diminished in these animals. No changes in LV function were observed in three dogs serving as time-matched controls. In three additional dogs, LV pressure was raised to a degree similar to that observed after SNS activation by constricting the ascending aorta for 1 h. These animals exhibited only modest shifts in the LV function curve during and after aortic constriction. Mean plasma catecholamine concentration increased by one to two orders of magnitude in animals after SNS activation, but only minor changes were observed in the other two groups. We conclude that myocardial contractility declines markedly soon after massive SNS activation and is not solely a function of the initial hypertensive period.

    Topics: Acidosis; Anesthesia; Animals; Blood Pressure; Cardiac Output; Catecholamines; Dogs; Female; Heart Rate; Heart Ventricles; Hypertension; Male; Microscopy, Electron; Sympathetic Nervous System; Ventricular Function, Left; Veratrine

1994
Kallikrein-kinin,enkephalin, renin-aldosterone and catecholamine systems in the vanadate (as vanadyl)-induced arterial hypertension.
    Agents and actions. Supplements, 1992, Volume: 38 ( Pt 3)

    Exposure to vanadate was found to induce arterial hypertension through effects on renin-angiotensin-aldosterone, renal peptidergic, and central and peripheral catecholaminergic systems. Vanadate increased, mainly in vascular myocells, both receptor-operated Ca2+ channel- and cyclic-AMP-dependent availability of Ca2+ for contractile processes. Vanadate was selectively accumulated by tissues in the +4 oxidation state (vanadyl).

    Topics: Aldosterone; Animals; Blood Pressure; Bradykinin; Bucladesine; Catecholamines; Diastole; Enkephalins; Heart Rate; Hypertension; Hypothalamus; Isoproterenol; Kallikreins; Lysine Carboxypeptidase; Male; Myocardium; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Systole; Time Factors; Vagotomy; Vanadates; Veratrine

1992
[Pharmacology of antihypertensive agents (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1974, May-21, Volume: 63, Issue:20

    Topics: Antihypertensive Agents; Blood Pressure; Bretylium Compounds; Diuretics; Evaluation Studies as Topic; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Methyldopa; Propranolol; Reserpine; Veratrine

1974
Histamine liberation into the cerebrospinal fluid by the drugs applied intraventricularly.
    Japanese journal of pharmacology, 1969, Volume: 19, Issue:4

    Topics: Alkaloids; Animals; Blood Pressure; Cerebral Ventricles; Diphenhydramine; Histamine; Histamine Release; Hypertension; Morphine; Perfusion; Rabbits; Respiration; Spectrophotometry; Tubocurarine; Veratrine

1969
[Oral depot-veratrine in therapy of hypertensive diseases].
    Munchener medizinische Wochenschrift (1950), 1955, Sep-30, Volume: 97, Issue:39

    Topics: Hypertension; Veratrine; Veratrum Alkaloids

1955
The effects of intravenous protoveratrine on hemodynamics and exercise tolerance in patients with hypertension.
    The American journal of the medical sciences, 1951, Volume: 222, Issue:2

    Topics: Blood Pressure; Exercise; Exercise Tolerance; Hemodynamics; Humans; Hypertension; Protoveratrines; Veratrine

1951
Effects of protoveratrine on the circulation in hypertension.
    The Journal of laboratory and clinical medicine, 1950, Volume: 36, Issue:5

    Topics: Biological Phenomena; Blood Circulation; Blood Pressure; Blood Pressure Determination; Hypertension; Physiological Phenomena; Protoveratrines; Veratrine

1950
Veratrum viride, bio-assayed, in treatment of essential hypertension.
    Texas state journal of medicine, 1950, Volume: 46, Issue:2

    Topics: Biological Assay; Blood Pressure; Blood Pressure Determination; Essential Hypertension; Hypertension; Veratrine; Veratrum

1950
Clinical studies on veratrum alkaloids; the action of protoveratrine and veratridine in hypertension.
    Circulation, 1950, Volume: 1, Issue:2

    Topics: Biomedical Research; Blood Pressure; Blood Pressure Determination; Hypertension; Protoveratrines; Veratridine; Veratrine; Veratrum Alkaloids

1950